NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
74 hedge funds and large institutions have $46.7M invested in Navidea Biopharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
24% less call options, than puts
Call options by funds: $65K | Put options by funds: $85K
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Holders
74
Holding in Top 10
1
Calls
$65K
Puts
$85K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$93.3K | |
| 3 | +$92K | |
| 4 |
Citigroup
New York
|
+$77.9K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$67K |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$807K | |
| 3 | -$272K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$196K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$157K |